Gut Bacterium's Sugar Burns Visceral Fat, Duke-Led Study Finds
Scientists at Duke-NUS and Duke University School of Medicine found that a gut bacterium, Clostridium immunis, produces a sugar that makes visceral fat burn more energy — trimming weight gain without cutting food or adding exercise. Gene data from 4,145 people ties the same molecule to lower obesity rates, and the team has already filed a patent.
- Original source: medicalxpress.com.
- The source published it on Nov 19, 2026 at 11:40 AM.
- Not verified by major outlets. This story may be false.
- No second outlet has reported it yet. Treat it as a single-source claim.
The microbe is Clostridium immunis, a gut resident that churns out a sugar molecule called an exopolysaccharide, or EPS. On its own the sugar is inert: it only works once a small chemical group, phosphocholine, gets attached — a kind of molecular on switch. The results appear in Cell Host & Microbe.
Flip that switch and visceral fat starts burning. The phosphocholine-tagged sugar lowered levels of IL-22, a protein the immune system uses to talk to the small intestine and visceral fat, which in turn raised the number of cells carrying UCP1 — the protein that lets fat cells dump energy as heat. The effect showed up specifically in visceral fat, the stubborn tissue wrapped around internal organs that usually resists burn-energy signals. It happened without the animals eating less or moving more.
First author Dr. Tan Chin Yee, who began the work as an M.D.-Ph.D. student at Duke-NUS and Duke's Department of Molecular Genetics and Microbiology and is now with the SingHealth Internal Medicine Residency Program, said the mechanism caught the team off guard: the bacterial sugar changed how visceral fat used energy rather than reducing food intake or increasing activity.
The team also went looking in people. Sifting metagenomic data from 4,145 individuals worldwide, they found that those with obesity carried fewer copies of the gene that attaches phosphocholine than people with a BMI below 25 — the range international standards define as healthy or normal weight. Senior author Assistant Professor Neeraj Surana, of Duke University School of Medicine's Department of Pediatrics and the SingHealth Duke-NUS Academic Medical Center, said the work shows how gut bacteria generate distinctive molecules by chemically modifying the sugars they make, opening new angles on microbiome-driven metabolism.
The stakes are big. Half the world's population is expected to be overweight or obese by 2035, and more than 12% of Singapore's population already lives with obesity. Professor Sheemei Lok, interim vice dean for research at Duke-NUS, said the study moves past the bare association between gut microbes and obesity by pinning down a specific molecule, a specific mechanism and a potential therapeutic pathway.
Next up: the researchers have filed a patent covering C. immunis and its sugar, and they plan clinical trials in the U.S. to test whether targeting the bacterium can treat obesity, with the longer-term aim of turning it into a therapy.
TopicsDuke-NUS Medical School · Duke University School of Medicine · Clostridium immunis · Cell Host & Microbe · Tan Chin Yee · Neeraj Surana · Sheemei Lok · UCP1
Source: medicalxpress.com
Written by AI from verified reporting.
More stories
- Health & science x.com 0 viewsFiona the hippo swallowed a knit cap, so the Cincinnati Zoo borrowed a horse farm's vibration plate
- Health & science clinicaladvisor.com 0 viewsFDA Clears Roche's Once-Daily Giredestrant for Hard-to-Treat Breast Cancer
- Health & science scitechdaily.com 0 viewsFDA Approves First-in-Class Blood Pressure Pill That May Also Shield Kidneys
- Health & science finance.yahoo.com 2 sources 0 viewsFDA clears Regeneron's RNAi myasthenia drug at $410,000 a year

